Home Cart Sign in  
Chemical Structure| 30045-16-0 Chemical Structure| 30045-16-0

Structure of Dehydrocorydaline
CAS No.: 30045-16-0

Chemical Structure| 30045-16-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dehydrocorydaline (13-Methylpalmatine) is an alkaloid that regulates the protein expression of Bax and Bcl-2, activates caspase-7 and caspase-8, and inactivates PARP. It elevates p38 MAPK activation, has anti-inflammatory and anti-cancer activities, shows strong anti-malarial effects (IC50 = 38 nM), and exhibits low cytotoxicity (cell viability > 90%) using the P. falciparum 3D7 strain.

Synonyms: 13-Methylpalmatine; Dehydrocorydalin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Dehydrocorydaline

CAS No. :30045-16-0
Formula : C22H24NO4
M.W : 366.43
SMILES Code : CC1=C(C=CC(OC)=C2OC)C2=C[N+]3=C1C4=CC(OC)=C(OC)C=C4CC3
Synonyms :
13-Methylpalmatine; Dehydrocorydalin
MDL No. :MFCD00887635
InChI Key :RFKQJTRWODZPHF-UHFFFAOYSA-N
Pubchem ID :34781

Safety of Dehydrocorydaline

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Dehydrocorydaline

epigenetics
DNA
MAPK
pyroptosis
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Bone marrow-derived macrophages 50 µM, 100 µM 12 hours Dehydrocorydaline significantly downregulated the mRNA levels of IL-1β and IL-18 in a time- and concentration-dependent manner. Acta Pharmacol Sin. 2022 Jun;43(6):1408-1418.
Bone marrow-derived macrophages 100 µM 24 hours Through RNA-seq analysis, Dehydrocorydaline significantly downregulated 825 genes, including 260 upregulated genes and 565 downregulated genes, indicating its inhibition of macrophage inflammatory responses. Acta Pharmacol Sin. 2022 Jun;43(6):1408-1418.
Human chondrocytes 10 µM 48 hours Dehydrocorydaline significantly promoted the cell activity of normal human chondrocytes without showing cytotoxicity. Moreover, 10 and 20 μM DHC clearly restored cell proliferation, inhibited mRNA and protein expression levels of type I collagen, MMP 1/13, and Cox2, and further increased those of aggrecan and type II collagen in the TNF-α-treated human chondrocytes. Int J Mol Sci. 2022 Jun 30;23(13):7268.
Human chondrocytes 20 µM 48 hours Dehydrocorydaline significantly promoted the cell activity of normal human chondrocytes without showing cytotoxicity. Moreover, 10 and 20 μM DHC clearly restored cell proliferation, inhibited mRNA and protein expression levels of type I collagen, MMP 1/13, and Cox2, and further increased those of aggrecan and type II collagen in the TNF-α-treated human chondrocytes. Int J Mol Sci. 2022 Jun 30;23(13):7268.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Anterior cruciate ligament transection (ACLT)-induced osteoarthritis model Intra-articular injection 1 mM Daily for the third week, then once every 3 days for the next 3 weeks Dehydrocorydaline significantly attenuated OA development, inhibited the enzymatic hydrolysis of ECM, and reduced phosphorylated JAK1 and STAT3 protein expression in vivo after ACLT for 6 weeks. Int J Mol Sci. 2022 Jun 30;23(13):7268.
ApoE−/− mice Atherosclerosis model Intraperitoneal injection 5 mg/kg Daily for 12 weeks Dehydrocorydaline significantly inhibited the development of atherosclerosis, improved aortic compliance, and increased plaque stability. Additionally, Dehydrocorydaline attenuated systemic and vascular inflammation in ApoE?/? mice. Acta Pharmacol Sin. 2022 Jun;43(6):1408-1418.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.73mL

0.55mL

0.27mL

13.65mL

2.73mL

1.36mL

27.29mL

5.46mL

2.73mL

References

 

Historical Records

Categories